These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10756552)

  • 21. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial.
    Blumenthal MN; Casale TB; Fink JN; Uryniak T; Casty FE
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):7-13. PubMed ID: 9449494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reformulation of Stmerin(®) D CFC formulation using HFA propellants.
    Murata S; Izumi T; Ito H
    Pharm Dev Technol; 2013; 18(6):1314-8. PubMed ID: 22519407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
    Hartung TK; Allbutt H; Dewar M; Innes JA; Crompton GK
    Respiration; 2002; 69(4):314-9. PubMed ID: 12169743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
    Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
    Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
    J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
    Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhalers of the future? A review of dry powder devices on the market today.
    Smith IJ; Parry-Billings M
    Pulm Pharmacol Ther; 2003; 16(2):79-95. PubMed ID: 12670777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transition to CFC-free metered dose inhalers--into the new millennium.
    McDonald KJ; Martin GP
    Int J Pharm; 2000 May; 201(1):89-107. PubMed ID: 10867268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled corticosteroids for adult asthma: impact of formulation and delivery device on relative pharmacokinetics, efficacy and safety.
    Shaw RJ
    Respir Med; 1999 Mar; 93(3):149-60. PubMed ID: 10464870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress of research on pressurized metered dose inhalers].
    Zhou X
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147
    [No Abstract]   [Full Text] [Related]  

  • 36. Alcohol-based pressurised metered-dose inhalers for use in asthma: a descriptive study.
    Alrasbi M; Sheikh A
    Prim Care Respir J; 2008 Jun; 17(2):111-3. PubMed ID: 18338091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: inhaled beclomethassone (BDP) with non-CFC propellent (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma (Respir Med 19999; 93:245-251).
    Zanen P
    Respir Med; 2000 Feb; 94(2):180-1. PubMed ID: 10714429
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin.
    Dockhorn RJ; Wagner DE; Burgess GL; Hafner KB; Letourneau K; Colice GL; Klinger NM
    Ann Allergy Asthma Immunol; 1997 Jul; 79(1):85-8. PubMed ID: 9236507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA-134a) is equivalent to BDP-CFC for the treatment of asthma: Milanowski et al. (Respir Med 1999; 93: 245-251).
    Ayres JG
    Respir Med; 2000 Feb; 94(2):181-2; author reply 183. PubMed ID: 10714430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.